Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use SUGAMMADEX INJECTION safely and effectively. See full prescribing information for SUGAMMADEX INJECTION. SUGAMMADEX injection, for intravenous use Initial U.S. Approval: 2015
Medication labelWhy this: Advisory · dailymed-prescription
Sugammadex is indicated for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adult and pediatric patients aged 2 years and older undergoing surgery. Additional pediatric use information is approved for Merck Sharp & Dohme LLC’s BRIDION® (sugammadex) injection. However, due to Merck Sharp & Dohme LLC’s marketing exclusivity rights, this drug product is not labeled with that information.
- generic_name
- sugammadex
- product_names
- Sugammadex
- ndc
- 0264-8200, 0264-8200-01, 0264-8200-10
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en